RealSeq Biosciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RealSeq Biosciences, Inc. - overview
Established
2019
Location
Santa Cruz, CA, US
Primary Industry
Biotechnology
About
Founded in 2019 and based in California, US, RealSeq Biosciences, Inc. operates as a developer of RNA fragmentomics technology that allows real-time detection of diseases. The company was founded by its CEO, Sergio Barberan-Soler. In March 2024, RealSeq Biosciences raised seed funding co-led by Charleston Angel Partners, Santa Clara Ventures, and Santa Cruz Ventures.
RealSeq Biosciences develops RNA technologies that leverage RNA fragmentomics to create tools for disease detection. The company offers library preparation kits like RealSeq®-AC, a small RNA library preparation kit for collecting standard RNA samples from tissues or cells; RealSeq®-Biofluids, a small RNA library preparation kit for collecting RNA samples from biofluids; RealSeq® Dual Index 12RXN; RealSeq® Size Select Beads; miND® spike-in; Selective Suppression Probes - SSP™; and many more. The firm provides a RiboMarker® platform that develops RNA-based markers to identify and track disease progression from diseases like cancer, fungal diseases, and infectious diseases. The company plans to use the funds raised in March 2024 to accelerate the development of its Ribomarker platform and liquid biopsy program.
Current Investors
Tech Coast Angels, Chemical Angel Network, Angel Star Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics
Website
www.realseqbiosciences.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.